Individualized Menopause Care
Available February 15, 2024- February 14, 2025
Physicians may earn a maximum of 1.5 AMA PRA Category 1 Credits™
Innovating Menopause Management: Check In On Menopause
AMWA is promoting a model of care to establish a dedicated appointment for patients approaching the menopausal transition. This approach ensures a consistent, individualized plan that encompass the evaluation and management of menopausal symptoms and elevated risk for common comorbidities such as CVD, osteoporosis.
The experience of menopause differs significantly from patient to patient, yet many physicians do not have sufficient training to adequately manage menopausal symptoms. Couple that with bias and trauma, which are associated with more severe menopause symptoms, and becomes a health disparity issue.
This CME course introduces the concept of creating a dedicated appointment for every patient with menopause so as to establish an individualized plan. Implementing the AMWA Check In On Menopause approach will assure that time is devoted to the often troublesome but overlooked symptoms as well as consider any elevated chronic disease risks, including considerations of any social determinants of health.
The ultimate goal is to improve healthcare by establishing a patient-centered treatment plan that ensures regular, targeted follow-up care to monitor health outcomes and make adjustments to treatment throughout menopause.
Juliana (Jewel) Kling, MD MPH MSCP FACP
Professor of Medicine, Suzanne Hanson Poole Dean, and Chair of Women’s Health/Internal Medicine
Mayo Clinic Alix School of Medicine – Arizona Campus
Jaya M. Mehta, MD, MSCP
Primary Care physician at Allegheny Health Network in Pittsburgh, PA.
Reference: Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405-420
Continuing Education Information
In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and AMWA. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Indiana University School of Medicine designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all financial relationships with any ineligible companies so that IUSM may identify and mitigate any conflicts of interest prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.
There are no relevant financial relationship(s) with ineligible companies for anyone who was in control of the content of this activity.
An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
This activity is supported by an educational grant from Pfizer